Know Cancer

or
forgot password

Plasma Cobalamin, Folate, Pyridoxine and Homocysteine Levels and Thrombosis in Patients With Philadelphia-chromosome-negative Myeloproliferative Neoplasms


N/A
18 Years
N/A
Not Enrolling
Both
Thrombosis

Thank you

Trial Information

Plasma Cobalamin, Folate, Pyridoxine and Homocysteine Levels and Thrombosis in Patients With Philadelphia-chromosome-negative Myeloproliferative Neoplasms


Thirty-one new or formerly diagnosed MPN patients who consecutively visitted our outpatient
clinic, as well as 40 age and sex matched healthy controls were enrolled in this study.


Inclusion Criteria:



Adult MPN patients and healthy controls who gave a written consent were included in the
study.

Exclusion Criteria:

Exclusion criteria included not giving a written consent and using medications without an
indication which may have an effect on plasma homocysteine and vitamin levels.

Type of Study:

Observational [Patient Registry]

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Thrombosis

Outcome Time Frame:

at least 1 year

Safety Issue:

No

Principal Investigator

Ahmet Emre Eskazan, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Istanbul University

Authority:

Turkey: Ethics Committee

Study ID:

HcyMPN

NCT ID:

NCT01878916

Start Date:

January 2003

Completion Date:

June 2004

Related Keywords:

  • Thrombosis
  • the incidence of thrombosis,
  • the effect of Hcy on thrombosis formation,
  • the relation between Hcy and plasma vitamin levels,
  • to compare these results with the control group
  • Myeloproliferative Disorders
  • Philadelphia Chromosome
  • Thrombosis

Name

Location